LifeMD Inc. 8.875% Series A Cumulative Perpetual Preferred Stock (LFMDP)

FairStock Score: 41/100 — MIXED

Key Financials

AI Analysis

AI-generated, general educational analysis — not personal investment advice.

I approach LifeMD's preferred as a creditor-like investor, not as a common-stock dreamer. The 8.875% Series A cumulative perpetual preferred pays $2.21875 annually on a $25 par, and at $22.48 the quoted yield is 9.59%. That is attractive only if the dividend is safe. The business is a direct-to-patient telehealth platform with Rex MD and ShapiroMD. It has scale—for FY2025, the year ended 2025-12-31, revenue was $194.1M—but little durable moat. Telehealth is competitive, customer acquisition is expensive, and switching costs are low. The Lynch category is turnaround, because for FY2025 net income was $14.4M versus FY2024, the year ended 2024-12-31, net loss of $21.4M. That is real progress. Yet the latest filed quarters are troubling: in fiscal Q2 2026, the quarter ended 2026-06-30, net loss was $7.1M; in fiscal Q1 2026, the quarter ended 2026-03-31, net loss was $8.9M; in fiscal Q3 2025, the quarter ended 2025-09-30, net loss was $3.8M. Trailing free cash flow is -$18.3M, FCF yield -1.7%. FairStock's Altman Z-score of 7.07 suggests low bankruptcy risk, and D/E 0.76 is manageable. But P/B is 132.24. The preferred is cumulative, so unpaid dividends accrue, but accrual is not cash. With negative FCF, coverage likely depends on cash reserves or financing, not operations. The price is near the 52-week high of $24.20 and above the low of $18.50, so there is no obvious margin of safety. I would want to see sustained positive net income, positive operating cash flow, and clear preferred dividend coverage before calling this a sound value. The yield is high because the risk is high.

In plain English: LifeMD is a telehealth company that sells virtual medical care and pharmacy services, including men's health brands. The business looks weak right now: it lost money in the latest quarters and its cash flow was negative, even though it reported a profit for the full 2025 year. The preferred stock pays a high dividend, but at $22.48 it trades near the top of its yearly range, so the price looks full given the current losses and uncertainty about the dividend.

The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.

Data as of 2026-10-13 close · note generated 2026-10-15 · model deepseek-flash

Sources (SEC EDGAR): fiscal Q2 2026 10-Q (period ended 2026-06-30) · fiscal Q1 2026 10-Q (period ended 2026-03-31) · fiscal Q3 2025 10-Q (period ended 2025-09-30) · fiscal Q2 2025 10-Q (period ended 2025-06-30) · FY2025 10-K (period ended 2025-12-31) · FY2024 10-K (period ended 2024-12-31) · FY2023 10-K (period ended 2023-12-31)

Fundamentals from company filings and market-data providers; prices are end-of-day, not real-time. AI-generated analysis is general and educational — not personal investment advice. Scoring methodology · Score test · Disclaimer